rethinkTHC Search
Menu
Study breakdown

Boosting a Natural Brain Cannabinoid Enhanced Fear Memory Through CB2 Receptors in Rats

Animal StudyPreliminary evidence
The takeaway

Inhibiting the breakdown of the endocannabinoid 2-AG strengthened fear memory consolidation in rats through CB2 receptor activation and suppression of mTOR signaling in the hippocampus.

Neuroscientists, PTSD researchers, endocannabinoid system researchers.

Memory enhancement was blocked by a CB2 antagonist but not a CB1 antagonist, pinpointing CB2 as the key receptor for 2-AG's memory effects.

What the researchers found

The MAGL inhibitor JZL184, which boosts 2-AG levels, enhanced memory consolidation when given right after training in a fear-based learning task. This effect was mediated specifically through CB2 receptors and involved suppression of the mTOR signaling pathway in the hippocampus.

Why it matters

Most endocannabinoid research on memory has focused on CB1 receptors. This study reveals that 2-AG and CB2 receptors play a fundamental role in how the brain consolidates memories of aversive experiences, opening a new research direction.

The numbers in context

JZL184 enhanced memory consolidation. CB2 antagonist AM630 blocked the effect, while CB1 antagonist AM251 did not. 2-AG signaling prevented mTOR activation in the hippocampus via CB2.

How the study worked

Rats were trained on an inhibitory avoidance task (a fear-based learning paradigm). JZL184 was administered immediately after training. CB1 and CB2 antagonists were used to determine which receptor mediated the memory effect. mTOR pathway components were measured in hippocampal tissue.

What this study cannot tell us

Animal study with acute drug administration. The inhibitory avoidance task measures a specific type of memory. Results may not generalize to other memory types or to humans.

How to read the evidence

Preliminary - single animal study, though mechanistically detailed with multiple validation approaches.

When this study was published

Published in 2018.

The bigger picture

Understanding how the endocannabinoid system modulates memory for stressful events has implications for conditions like PTSD, where traumatic memories are abnormally persistent. CB2-targeted therapies could potentially modulate this process without the psychoactive effects associated with CB1.

Questions still open

  • Could CB2-targeted drugs help regulate traumatic memory formation in humans? Does this 2-AG/CB2 pathway contribute to the memory effects reported by cannabis users? How does this interact with the previously identified anandamide/CB1 pathway?

Common questions

How does the endocannabinoid system affect memory?
This study showed that the endocannabinoid 2-AG strengthens memory consolidation for aversive experiences through CB2 receptors. Previous work found anandamide does something similar through CB1 receptors, suggesting both major endocannabinoids regulate emotional memory.
What is 2-AG?
2-arachidonoylglycerol (2-AG) is one of the two major endocannabinoids - molecules the brain naturally produces that act on the same receptors as THC. It is the most abundant endocannabinoid in the brain.

Read the original research

Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.

Neuropharmacology, 138, 210-218

Citation

Ratano, Patrizia; Petrella, Carla; Forti, Fabrizio; Passeri, Pamela Petrocchi; Morena, Maria; Palmery, Maura; Trezza, Viviana; Severini, Cinzia; Campolongo, Patrizia. (2018). Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.. Neuropharmacology, 138, 210-218. https://doi.org/10.1016/j.neuropharm.2018.05.030

Explore the wider topic